Prospective trial of radiotherapy after hyperbaric oxygenation with chemotherapy for high-grade gliomas.
Twenty-one patients with high-grade gliomas were enrolled in a prospective trial of radiotherapy after hyperbaric oxygenation (HBO). Radiotherapy was administered in daily 2-Gy fractions up to a total dose of 60 Gy, and each fraction was delivered immediately after HBO. The current study indicated that radiotherapy immediately after HBO with chemotherapy was feasible for high-grade gliomas.
Ogawa
Kazuhiko
K
Department of Radiology, University of the Ryukyus, School of Medicine, 207 Uehara, Nishihara-cho, 903-0215, Okinawa, Japan.
Yoshii
Yoshihiko
Y
Inoue
Osamu
O
Toita
Takafumi
T
Saito
Atsushi
A
Kakinohana
Yasumasa
Y
Adachi
Genki
G
Ishikawa
Yasunari
Y
Kin
Shigenari
S
Murayama
Sadayuki
S
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005260:Female; D005909:Glioblastoma / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy; D005910:Glioma / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D006801:Humans; D006931:Hyperbaric Oxygenation; D007564:Japan; D008297:Male; D008875:Middle Aged; D015376:Nimustine / Q000008:administration & dosage; D011344:Procarbazine / Q000008:administration & dosage; D011446:Prospective Studies; D015173:Supratentorial Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D015996:Survival Rate; D014750:Vincristine / Q000008:administration & dosage
D015376:Nimustine; D011344:Procarbazine; D014750:Vincristine